Language
English
Publication Date
4-1-2025
Journal
Ophthalmology Retina
DOI
10.1016/j.oret.2024.12.021
PMID
39733838
Keywords
Criteria. Disease Activity. Durability. Faricimab. Neovascular age-related macular degeneration
Published Open-Access
yes
Recommended Citation
Zarbin, Marco A; Weng, Christina Y; London, Nikolas J S; et al., "Disease Activity Criteria Impact Dosing Interval Assignment in Neovascular Age-related Macular Degeneration Trials" (2025). Faculty and Staff Publications. 5508.
https://digitalcommons.library.tmc.edu/baylor_docs/5508